ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
Protara Therapeutics Inc

Protara Therapeutics Inc (TARA)

5,31
-0,25
(-4,50%)
Fermé 14 Janvier 10:00PM
5,0591
-0,2509
(-4,73%)
Après les heures de négociation: 1:59AM

Votre Hub pour des idées et discussions en direct en temps réel

Statistiques et détails clés

Dernier
5,31
Prix Achat
5,04
Prix Vente
5,83
Volume échangé
264 944
5,10 Fourchette du Jour 5,50
1,595 Plage de 52 semaines 10,48
Cap du marché
Clôture Veille
5,56
Ouverture
5,47
Dernière Transaction
5
@
5.15
Dernière heure de transaction
Volume financier
US$ 1 394 566
VWAP
5,2636
Volume moyen (3 m)
2 550 110
Actions en circulation
20 629 772
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-0,43
Bénéfice par action (BPA)
-1,96
Chiffre d'affairess
-
Bénéfice net
-40,42M

À propos de Protara Therapeutics Inc

Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with rare and specialty diseases. The Protara team prioritizes creativity, diverse perspectives and tenacity to expedite our goal of bringing life-changing therapies to people with limited treatmen... Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with rare and specialty diseases. The Protara team prioritizes creativity, diverse perspectives and tenacity to expedite our goal of bringing life-changing therapies to people with limited treatment options. The company discovers, develops, and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD). Show more

Secteur
Biological Pds,ex Diagnstics
Industrie
Biological Pds,ex Diagnstics
Site Web
Siège social
Wilmington, Delaware, USA
Fondé
-
Protara Therapeutics Inc est coté dans le secteur Biological Pds,ex Diagnstics de la NASDAQ avec le ticker TARA. Le dernier cours de clôture d'Protara Therapeutics était de US$5,56. Au cours de la dernière année, les actions de Protara Therapeutics ont été négociées dans une fourchette de prix de US$ 1,595 à US$ 10,48.

Protara Therapeutics compte actuellement 20 629 772 actions en circulation. La capitalisation boursière d'Protara Therapeutics est de US$114,70 million. Protara Therapeutics a un ratio cours/bénéfice (ratio PE) de -0.43.

TARA Dernières nouvelles

Protara Highlights Recent Updates and Anticipated 2025 Milestones

Reported positive six-month data from ADVANCED-2 trial of TARA-002 in patients with NMIBC Completed approximately $100 million public offering, extending runway into 2027 Initial data from...

Protara Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

NEW YORK, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases...

Protara Announces Closing of $100 Million Public Offering

NEW YORK, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases...

Protara Announces Pricing of $100 Million Public Offering

NEW YORK, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA) (“Protara”), a clinical-stage company developing transformative therapies for the treatment of cancer and...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.89-14.35483870976.26.25.03844862695.85164339CS
4-0.53-9.075342465755.846.24.916254045.48166261CS
123.36172.3076923081.9510.481.7825501105.80601521CS
262.93123.1092436972.3810.481.59512329235.55916193CS
523.03132.8947368422.2810.481.5957549585.15054312CS
156-1.06-16.64050235486.3710.481.042732034.97127728CS
260-19.89-78.928571428625.267.0791.042053746.59958747CS

TARA - Frequently Asked Questions (FAQ)

What is the current Protara Therapeutics share price?
The current share price of Protara Therapeutics is US$ 5,31
How many Protara Therapeutics shares are in issue?
Protara Therapeutics has 20 629 772 shares in issue
What is the market cap of Protara Therapeutics?
The market capitalisation of Protara Therapeutics is USD 114,7M
What is the 1 year trading range for Protara Therapeutics share price?
Protara Therapeutics has traded in the range of US$ 1,595 to US$ 10,48 during the past year
What is the PE ratio of Protara Therapeutics?
The price to earnings ratio of Protara Therapeutics is -0,43
What is the reporting currency for Protara Therapeutics?
Protara Therapeutics reports financial results in USD
What is the latest annual profit for Protara Therapeutics?
The latest annual profit of Protara Therapeutics is USD -40,42M
What is the registered address of Protara Therapeutics?
The registered address for Protara Therapeutics is CORPORATION TRUST CENTER, 1209 ORANGE ST, WILMINGTON, DELAWARE, 19801
What is the Protara Therapeutics website address?
The website address for Protara Therapeutics is protaratx.com
Which industry sector does Protara Therapeutics operate in?
Protara Therapeutics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
PHIOPhio Pharmaceuticals Corporation
US$ 6,50
(284,62%)
281,98M
SLRXSalarius Pharmaceuticals Inc
US$ 3,65
(133,23%)
120,26M
VRMEVerifyMe Inc
US$ 4,1575
(63,04%)
57,6M
ATPCAgape ATP Corporation
US$ 1,9645
(55,91%)
84,16M
AVGRAvinger Inc
US$ 0,8248
(46,47%)
9,78M
EHGOEshallgo Inc
US$ 1,2408
(-62,06%)
6,74M
CMTLComtech Telecommunications Corporation
US$ 2,3491
(-43,12%)
4,37M
SVMHSRIVARU Holding Ltd
US$ 0,0352
(-43,04%)
184,27M
LAESSEALSQ Corporation
US$ 3,35
(-41,54%)
89,92M
NMHINatures Miracle Holding Inc
US$ 1,12
(-38,80%)
735,08k
GCTKGlucoTrack Inc
US$ 0,1493
(27,61%)
685,02M
PHIOPhio Pharmaceuticals Corporation
US$ 6,50
(284,62%)
281,98M
BHATBlue Hat Interactive Entertainment Technology
US$ 0,0627
(-28,83%)
232,25M
NVDANVIDIA Corporation
US$ 133,23
(-1,97%)
204,68M
RGTIRigetti Computing Inc
US$ 6,0344
(-32,43%)
192,21M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock